SeaStar Medical Holding Corporation
ICUNASDAQHealthcare● Active
$2.90
$-0.04(-1.36%)
Market Cap$8230038
P/E Ratio—
52W High$12.9
52W Low$2.07
SeaStar Medical Holding Corporation (ICU) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ICU · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 13, 2026EPS Actual
-$0.90
Est. -$0.73 · -23.3%
Revenue
$0.00B
Est. $0.00B · +13.1%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 13, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
ICU reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 12, 2026 | -$0.97 | — | — | — | $0.00B | — |
| ▼ Q2 FY2026 | May 13, 2026 | -$0.73 | -$0.90 | -23.3% | $0.00B | $0.00B | +13.1% |
| ▲ Q1 FY2026 | Mar 25, 2026 | -$0.97 | -$0.80 | +17.5% | $0.00B | $0.00B | +88.8% |
| ▲ Q4 FY2025 | Nov 13, 2025 | -$1.50 | -$1.30 | +13.3% | $0.00B | $0.00B | -26.8% |
| ▲ Q3 FY2025 | Aug 13, 2025 | -$0.43 | -$0.18 | +58.1% | $0.00B | $0.00B | +38.0% |
| ▲ Q2 FY2025 | May 14, 2025 | -$0.52 | -$0.44 | +15.4% | $0.00B | $0.00B | +95.3% |
| ▼ Q1 FY2025 | Mar 27, 2025 | -$0.89 | -$0.90 | -1.1% | $0.00B | $0.00B | -55.3% |
| ▲ Q4 FY2024 | Nov 13, 2024 | -$1.13 | -$1.10 | +2.6% | $0.00B | $0.00B | -54.7% |
Q3 FY2026
Aug 12, 2026
EPS Actual
—
EPS Est.
-$0.97
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 13, 2026Miss
EPS Actual
-$0.90
EPS Est.
-$0.73
EPS Surpr.
-23.3%
Revenue
$0.00B
Q1 FY2026
Mar 25, 2026Beat
EPS Actual
-$0.80
EPS Est.
-$0.97
EPS Surpr.
+17.5%
Revenue
$0.00B
Q4 FY2025
Nov 13, 2025Beat
EPS Actual
-$1.30
EPS Est.
-$1.50
EPS Surpr.
+13.3%
Revenue
$0.00B
Q3 FY2025
Aug 13, 2025Beat
EPS Actual
-$0.18
EPS Est.
-$0.43
EPS Surpr.
+58.1%
Revenue
$0.00B
Q2 FY2025
May 14, 2025Beat
EPS Actual
-$0.44
EPS Est.
-$0.52
EPS Surpr.
+15.4%
Revenue
$0.00B
Q1 FY2025
Mar 27, 2025Miss
EPS Actual
-$0.90
EPS Est.
-$0.89
EPS Surpr.
-1.1%
Revenue
$0.00B
Q4 FY2024
Nov 13, 2024Beat
EPS Actual
-$1.10
EPS Est.
-$1.13
EPS Surpr.
+2.6%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $-0.94 | $-0.89 | $-0.84 | 1 |
| Q3 FY2026 | $-0.95 | $-0.90 | $-0.84 | 1 |
| Q2 FY2026 | $-1.03 | $-0.97 | $-0.91 | 1 |
| Q1 FY2026 | $-0.87 | $-0.82 | $-0.78 | 1 |
| Q4 FY2025 | $-1.14 | $-1.08 | $-1.02 | 1 |
| Q3 FY2025 | $-1.59 | $-1.50 | $-1.41 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 13, 2026 | -23.3% | $4.84 | $4.60 | -4.96% |
| ▲ Q1 FY2026 | Mar 25, 2026 | +17.5% | $2.24 | $2.28 | +1.79% |
| ▲ Q4 FY2025 | Nov 13, 2025 | +13.3% | $4.99 | $4.60 | -7.82% |
| ▲ Q3 FY2025 | Aug 13, 2025 | +58.1% | $7.30 | $7.27 | -0.41% |
| ▲ Q2 FY2025 | May 14, 2025 | +15.4% | $12.70 | $12.30 | -3.15% |
| ▼ Q1 FY2025 | Mar 27, 2025 | -1.1% | $24.30 | $22.00 | -9.47% |
| ▲ Q4 FY2024 | Nov 13, 2024 | +2.6% | $26.70 | $25.20 | -5.62% |
| ▲ Q3 FY2024 | Aug 13, 2024 | +26.9% | $72.70 | $60.70 | -16.51% |
Q2 FY2026-4.96%
Report Date
May 13, 2026
EPS Beat/Miss
-23.3%
Price Before
$4.84
Price After
$4.60
Q1 FY2026+1.79%
Report Date
Mar 25, 2026
EPS Beat/Miss
+17.5%
Price Before
$2.24
Price After
$2.28
Q4 FY2025-7.82%
Report Date
Nov 13, 2025
EPS Beat/Miss
+13.3%
Price Before
$4.99
Price After
$4.60
Q3 FY2025-0.41%
Report Date
Aug 13, 2025
EPS Beat/Miss
+58.1%
Price Before
$7.30
Price After
$7.27
Q2 FY2025-3.15%
Report Date
May 14, 2025
EPS Beat/Miss
+15.4%
Price Before
$12.70
Price After
$12.30
Q1 FY2025-9.47%
Report Date
Mar 27, 2025
EPS Beat/Miss
-1.1%
Price Before
$24.30
Price After
$22.00
Q4 FY2024-5.62%
Report Date
Nov 13, 2024
EPS Beat/Miss
+2.6%
Price Before
$26.70
Price After
$25.20
Q3 FY2024-16.51%
Report Date
Aug 13, 2024
EPS Beat/Miss
+26.9%
Price Before
$72.70
Price After
$60.70
Avg Beat Reaction-5.29%
Avg Miss Reaction-7.21%
Beat Rate6 / 8 quarters
Largest Move-16.51% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ICU ends December
SeaStar Medical Holding Corporation (ICU) most recently reported earnings on May 13, 2026 for Q2 FY2026, posting EPS of $-0.90 — missing the analyst consensus of $-0.73 by -23.3%. The next ICU earnings date is expected around September 1, 2026.
Each quarter, investors track ICU earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ICU revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ICU's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ICU earnings · 5 questionsSeaStar Medical Holding Corporation's next earnings report is expected around September 1, 2026. ICU typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ICU historically reports after market close (AMC).
ICU earnings datewhen is ICU earningsICU next earnings datewhen does ICU report earningsICU earnings calendar
▸ Source: FMP · SeaStar Medical Holding Corporation SEC filings · US GAAP · SeaStar Medical Holding Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026